|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02279 YONGHE MEDICAL
Nominal 
0.850 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 900,203 | 8.746% | 827,807 | 748,137 | 1,053,400 | 601,563 |
| Cost of Sales | (370,766) | 2.931% | (360,209) | (267,641) | (277,983) | (166,012) |
| Gross Profit | 529,437 | 13.225% | 467,598 | 480,496 | 775,417 | 435,551 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (80) | -71.014% | (276) | 90 | (376) | (279) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (146,699) | -42.791% | (256,428) | 13,274 | 88,875 | 93,541 | |
| Taxation | 8,051 | -73.374% | 30,237 | 4,355 | (48,434) | (28,082) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 76 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (138,572) | -38.737% | (226,191) | 17,629 | 40,441 | 65,459 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 16,050 | -48.715% | 31,296 | (36,695) | 20,270 | 15,789 |
| Depreciation & Amortisation | 168,575 | 10.817% | 152,120 | 108,883 | 97,067 | 74,478 |
| Directors' Emoluments | -- | -- | -- | -- | 1,023 | 4,390 |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | Unqualified | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | -28.000 | -36.364% | -44.000 | 3.000 | 10.000 | -- |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.526 | -- | 2.407 | 3.429 | -- | -- |
| Remarks: | Real time quote last updated: 20/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -138,572,000 |
| %Change | -38.737% |
| EPS / (LPS) | RMB -0.280 |
| NBV Per Share (¥) | RMB 1.526 |